Published in Gene Therapy Weekly, March 6th, 2003
"The chicken chorioallantoic membrane CAM assay represents one of the most widely used in vivo screening assays for genes with angiogenic (blood vessel-inducing) or angiostatic (inhibition of vessel formation or their destruction) activities," stated K. Schughart and coauthors, GBF, German Research Center for Biotechnology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.